Suppr超能文献

抑酸剂对胃排空的影响:健康志愿者的交叉分析

Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers.

作者信息

Takahashi Yoshiko, Amano Yuji, Yuki Takafumi, Ose Takayuki, Miyake Tatsuya, Kushiyama Yoshinori, Sato Shuichi, Ishihara Shunji, Kinoshita Yoshikazu

机构信息

Department of Gastroenterology and Hepatology, School of Medicine, Shimane University, Izumo-shi, Shimane, Japan.

出版信息

J Gastroenterol Hepatol. 2006 Nov;21(11):1664-8. doi: 10.1111/j.1440-1746.2006.04270.x.

Abstract

BACKGROUND

Gastric emptying plays an important role in gastroesophageal reflux disease. Acid suppressants such as H2 receptor antagonists and/or proton pump inhibitors are often used in patients with gastroesophageal reflux disease. However, it remains controversial whether H2 receptor antagonists and proton pump inhibitors delay or accelerate gastric emptying. Here, the influence of acid suppressants on gastric emptying was evaluated via a cross-over study using the [13C]-labeled acetate breath test.

METHODS

Twenty normal male subjects without gastroesophageal reflux disease symptoms were enrolled. Gastric emptying was investigated five times in every subject by the [13C]-labeled acetate breath test with oral administration of the vehicle, domperidone, and three acid suppressants: ranitidine, famotidine and rabeprazole. Gastric emptying was estimated by the values of T(max-calc), T(1/2) and %dose/2 h calculated from the 13CO2 breath excretion curve.

RESULTS

Using the T(max-calc) values, rabeprazole, ranitidine and famotidine did not influence gastric emptying time in comparison with vehicle administration. Using the T(1/2) and %dose/2 h values, rabeprazole tended to delay gastric emptying. Domperidone produced a statistically significant acceleration of gastric emptying for all three variables (P < 0.05).

CONCLUSION

Oral dosage of the H2 receptor antagonists, ranitidine and famotidine, has no significant effect on gastric emptying. However, rabeprazole may delay gastric emptying more strongly than H2 receptor antagonists.

摘要

背景

胃排空在胃食管反流病中起重要作用。H2受体拮抗剂和/或质子泵抑制剂等抑酸剂常用于胃食管反流病患者。然而,H2受体拮抗剂和质子泵抑制剂是延迟还是加速胃排空仍存在争议。在此,通过使用[13C]标记的乙酸呼气试验的交叉研究评估了抑酸剂对胃排空的影响。

方法

招募了20名无胃食管反流病症状的正常男性受试者。通过口服赋形剂、多潘立酮和三种抑酸剂(雷尼替丁、法莫替丁和雷贝拉唑)的[13C]标记的乙酸呼气试验,对每位受试者进行了五次胃排空研究。通过从13CO2呼气排泄曲线计算出的T(max-calc)、T(1/2)和%剂量/2小时的值来估计胃排空。

结果

使用T(max-calc)值,与给予赋形剂相比,雷贝拉唑、雷尼替丁和法莫替丁对胃排空时间没有影响。使用T(1/2)和%剂量/2小时的值,雷贝拉唑倾向于延迟胃排空。多潘立酮对所有三个变量均产生了统计学上显著的胃排空加速作用(P<0.05)。

结论

口服H2受体拮抗剂雷尼替丁和法莫替丁对胃排空无显著影响。然而,雷贝拉唑可能比H2受体拮抗剂更强烈地延迟胃排空。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验